Wolverine Trading’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.29M | Buy |
58,200
+13,100
| +29% | +$1.79M | 0.01% | 1039 |
|
|
2025
Q2 | $5.7M | Sell |
45,100
-100
| -0.2% | -$12.3K | 0.01% | 986 |
|
|
2025
Q1 | $5.89M | Sell |
45,200
-5,400
| -11% | -$732K | 0.01% | 905 |
|
|
2024
Q4 | $6.66M | Buy |
+50,600
| New | +$7.11M | 0.01% | 1022 |
|
|
2024
Q3 | – | Sell |
-107,900
| Closed | -$14.8M | – | 5048 |
|
|
2024
Q2 | $14.8M | Buy |
+107,900
| New | +$14.4M | 0.02% | 487 |
|
|
2024
Q1 | – | Sell |
-128,500
| Closed | -$17.5M | – | 4825 |
|
|
2023
Q4 | $17.5M | Buy |
+128,500
| New | +$15.7M | 0.02% | 502 |
|
|
2023
Q3 | – | Sell |
-56,600
| Closed | -$7.13M | – | 4763 |
|
|
2023
Q2 | $7.13M | Buy |
56,600
+17,700
| +46% | +$2.3M | 0.01% | 733 |
|
|
2023
Q1 | $4.95M | Buy |
+38,900
| New | +$5.09M | 0.01% | 844 |
|
|
2022
Q1 | – | Sell |
-66,600
| Closed | -$10.2M | – | 5848 |
|
|
2021
Q4 | $10.2M | Buy |
66,600
+1,700
| +3% | +$263K | 0.01% | 714 |
|
|
2021
Q3 | $10.5M | Sell |
64,900
-12,800
| -16% | -$2.15M | 0.01% | 772 |
|
|
2021
Q2 | $12.7M | Buy |
+77,700
| New | +$12M | 0.02% | 605 |
|
|
2021
Q1 | – | Sell |
-245,600
| Closed | -$37.4M | – | 6097 |
|
|
2020
Q4 | $37.4M | Sell |
245,600
-17,800
| -7% | -$2.54M | 0.06% | 221 |
|
|
2020
Q3 | $35.5M | Buy |
+263,400
| New | +$35.7M | 0.09% | 155 |
|
|
2020
Q2 | – | Sell |
-118,900
| Closed | -$12.9M | – | 4852 |
|
|
2020
Q1 | $12.9M | Buy |
+118,900
| New | +$13.7M | 0.04% | 346 |
|
|
2019
Q4 | – | Sell |
-89,900
| Closed | -$8.93M | – | 4863 |
|
|
2019
Q3 | $8.93M | Sell |
89,900
-193,600
| -68% | -$20.3M | 0.03% | 582 |
|
|
2019
Q2 | $30.9M | Buy |
+283,500
| New | +$30.2M | 0.09% | 176 |
|
|
2019
Q1 | – | Sell |
-337,400
| Closed | -$32M | – | 4837 |
|
|
2018
Q4 | $32M | Sell |
337,400
-33,200
| -9% | -$3.52M | 0.09% | 148 |
|
|
2018
Q3 | $45.2M | Buy |
370,600
+22,800
| +7% | +$2.68M | 0.1% | 116 |
|
|
2018
Q2 | $37.1M | Hold |
347,800
| – | – | 0.09% | 131 |
|
|
2018
Q1 | $37.1M | Sell |
347,800
-179,500
| -34% | -$19.9M | 0.09% | 131 |
|
|
2017
Q4 | $56.3M | Buy |
+527,300
| New | +$56.4M | 0.2% | 73 |
|
|
2017
Q3 | – | Sell |
-876,600
| Closed | -$91.3M | – | 4674 |
|
|
2017
Q2 | $91.3M | Buy |
+876,600
| New | +$86.3M | 0.42% | 31 |
|
|
2017
Q1 | – | Sell |
-495,000
| Closed | -$43.8M | – | 4597 |
|
|
2016
Q4 | $43.8M | Buy |
495,000
+197,400
| +66% | +$18M | 0.21% | 80 |
|
|
2016
Q3 | $28.4M | Sell |
297,600
-29,700
| -9% | -$2.83M | 0.13% | 152 |
|
|
2016
Q2 | $27.9M | Buy |
+327,300
| New | +$29.4M | 0.16% | 116 |
|
Other funds holding IBB
CB
Wolverine Trading's IBB Position: Q3 2025 in Review
Wolverine Trading reduced its iShares Biotechnology ETF (IBB) stake by 17% in Q3 2025, selling an estimated $348K and leaving 12,539 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2285.
Wolverine Trading first reported a position in IBB in Q2 2016 and has held it in 18 quarters since. The position peaked at $10.4M in Q2 2017. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.
- Wolverine Trading held 12,539 shares of iShares Biotechnology ETF worth $1.79M as of Q3 2025.
- Wolverine Trading sold 2,553 iShares Biotechnology ETF shares in Q3 2025, an estimated $348K.
- iShares Biotechnology ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2285 holding.
- Wolverine Trading first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 18 quarters since.
- Wolverine Trading's iShares Biotechnology ETF position peaked at $10.4M in Q2 2017.
- 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.